Abstract:
The Nanotechnology-Biology Interface conference at Cowles Auditorium on Thursday looked at how these bleeding-edge technologies affect everything from health and safety hazards to government regulation and the insurance industry.

Ken Keller, director of the Center for Science, Technology and Public Policy, said the goal of the conference was to anticipate some of the consequences of developing and using nanotechnology.